Forms of mineralocorticoid hypertension

被引:12
作者
Ferrari, P [1 ]
Bonny, O [1 ]
机构
[1] Univ Bern, Div Nephrol & Hypertens, Inselspital, CH-3010 Bern, Switzerland
来源
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66 | 2003年 / 66卷
关键词
D O I
10.1016/S0083-6729(03)01004-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertension with hypokalemia, metabolic alkalosis, and suppressed plasma renin activity defines mineralocorticoid hypertension. Mineralocorticoid hypertension is the consequence of an overactivity of the epithelial sodium channel expressed at the apical membrane of renal cells in the distal nephron. This is usually the case when the mineralocorticoid receptor is activated by its physiologic substrate aldosterone. The best known form of mineralocorticoid hypertension is an aldosterone-producing adrenal tumor leading to primary aldosteronism. Primary aldosteronism can also be caused by unilateral or bilateral adrenal hyperplasia and rarely adrenal carcinoma. Interestingly, most of the inherited monogenic disorders associated with hypertension involve an excessive activation of the mineralocorticoid axis. In some of these disorders, mineralocorticoid hypertension results from activation of the mineralocorticoid receptor by other steroids (cortisol, deoxycorticosterone), by primary activation of the receptor itself, or by constitutive overactivity of the renal epithelial sodium channel. The present review addresses the physiology and significance of the key players of the mineralocorticoid axis, placing emphasis on the conditions leading to mineralocorticoid hypertension. © 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:113 / 156
页数:44
相关论文
共 232 条
  • [1] Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients
    Abdelhamid, S
    MullerLobeck, H
    Pahl, S
    Remberger, K
    Bonhof, JA
    Walb, D
    Rockel, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (11) : 1190 - 1195
  • [2] Feedback inhibition of rat amiloride-sensitive epithelial sodium channels expressed in Xenopus laevis oocytes
    Abriel, H
    Horisberger, JD
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1999, 516 (01): : 31 - 43
  • [3] AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
  • [4] AGARWAL AK, 1989, J BIOL CHEM, V264, P18939
  • [5] CLONING OF CDNA-ENCODING AN NAD(+)-DEPENDENT ISOFORM OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN SHEEP KIDNEY
    AGARWAL, AK
    MUNE, T
    MONDER, C
    WHITE, PC
    [J]. ENDOCRINE RESEARCH, 1995, 21 (1-2) : 389 - 397
  • [6] CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME
    ALBISTON, AL
    OBEYESEKERE, VR
    SMITH, RE
    KROZOWSKI, ZS
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) : R11 - R17
  • [7] [Anonymous], 1974, RES STEROIDS
  • [8] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [9] Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in London
    Baker, EH
    Dong, YB
    Sagnella, GA
    Rothwell, M
    Onipinla, AK
    Markandu, ND
    Cappuccio, FP
    Cook, DG
    Persu, A
    Corvol, P
    Jeunemaitre, X
    Carter, ND
    MacGregor, GA
    [J]. LANCET, 1998, 351 (9113) : 1388 - 1392
  • [10] Inhibition of mineralocorticoid activity by the beta-isoform of the human glucocorticoid receptor
    Bamberger, CM
    Bamberger, AM
    Wald, M
    Chrousos, GP
    Schulte, HM
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 60 (1-2) : 43 - 50